NO20044164L - Farmasoytiske sammensetninger - Google Patents

Farmasoytiske sammensetninger

Info

Publication number
NO20044164L
NO20044164L NO20044164A NO20044164A NO20044164L NO 20044164 L NO20044164 L NO 20044164L NO 20044164 A NO20044164 A NO 20044164A NO 20044164 A NO20044164 A NO 20044164A NO 20044164 L NO20044164 L NO 20044164L
Authority
NO
Norway
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
NO20044164A
Other languages
English (en)
Inventor
Anees Abdulquadar Karnachi
Jurij Holinej
Maha Y Khaled
Yatindra Joshi
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20044164L publication Critical patent/NO20044164L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
NO20044164A 2002-03-07 2004-09-30 Farmasoytiske sammensetninger NO20044164L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36235102P 2002-03-07 2002-03-07
PCT/EP2003/002322 WO2003074041A1 (en) 2002-03-07 2003-03-06 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
NO20044164L true NO20044164L (no) 2004-09-30

Family

ID=27789154

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044164A NO20044164L (no) 2002-03-07 2004-09-30 Farmasoytiske sammensetninger

Country Status (20)

Country Link
US (4) US20030171437A1 (no)
EP (1) EP1492520A1 (no)
JP (1) JP2005519097A (no)
KR (1) KR20040089654A (no)
CN (1) CN1330300C (no)
AR (1) AR038747A1 (no)
AU (1) AU2003227039B2 (no)
BR (1) BR0308156A (no)
CA (1) CA2476744A1 (no)
CO (1) CO5650241A2 (no)
EC (1) ECSP045244A (no)
MX (1) MXPA04008665A (no)
NO (1) NO20044164L (no)
NZ (1) NZ534587A (no)
PE (1) PE20040288A1 (no)
PL (1) PL370907A1 (no)
RU (1) RU2318497C2 (no)
TW (1) TW200305443A (no)
WO (1) WO2003074041A1 (no)
ZA (1) ZA200406226B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8951996B2 (en) 2011-07-28 2015-02-10 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
EA033102B1 (ru) * 2017-08-21 2019-08-30 Общество с ограниченной ответственностью "Фармамед" Фармацевтическая композиция с модифицированным отсроченным и длительным высвобождением, содержащая аспарагинаты
WO2023113650A1 (ru) * 2021-12-15 2023-06-22 Владимир Евгеньевич НЕБОЛЬСИН Фармацевтическая композиция 1-[2-(1-метилимидазол-4-ил)-этил]пергидроазин-2,6-дион для терапии заболеваний верхних дыхательных путей

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3346525A1 (de) * 1983-12-22 1985-07-04 A. Nattermann & Cie GmbH, 5000 Köln Pharmazeutische zubereitung mit speziellen 1,2-diacyl-glycero-3-phosphocholinen zur behandlung von erkrankungen im magen-darmbereich
KR100208979B1 (ko) * 1992-06-12 1999-07-15 야스이 쇼사꾸 기도내 투여용 제제
DE69433012T2 (de) * 1993-06-08 2004-06-09 Novartis Ag Verfahren zur herstellung von oralen dosierungsformulierungen enthaltend diclofenac
NZ332670A (en) * 1996-05-17 2000-07-28 Merck & Co Inc Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases comprising 3-phenyl-4-(4-methylsulfonyl)phenyl)-2-(5H)-furanone
CO4960662A1 (es) * 1997-08-28 2000-09-25 Novartis Ag Ciertos acidos 5-alquil-2-arilaminofenilaceticos y sus derivados
DE19931708A1 (de) * 1999-07-08 2001-01-18 Bayer Ag Verfahren zur Herstellung schnell zerfallender, fester pharmazeutischer Zubereitungen
AR030630A1 (es) * 2000-09-11 2003-08-27 Novartis Ag Composiciones farmaceuticas
US20030114527A1 (en) * 2001-08-31 2003-06-19 Karnachi Anees Abdulquadar Pharmaceutical composition

Also Published As

Publication number Publication date
AU2003227039B2 (en) 2007-04-19
RU2004129770A (ru) 2005-05-10
PL370907A1 (en) 2005-05-30
CN1330300C (zh) 2007-08-08
US20090149543A1 (en) 2009-06-11
ZA200406226B (en) 2005-06-23
AU2003227039A1 (en) 2003-09-16
CO5650241A2 (es) 2006-06-30
ECSP045244A (es) 2004-09-28
BR0308156A (pt) 2005-01-04
WO2003074041A1 (en) 2003-09-12
US20070087051A1 (en) 2007-04-19
KR20040089654A (ko) 2004-10-21
CA2476744A1 (en) 2003-09-12
NZ534587A (en) 2007-08-31
TW200305443A (en) 2003-11-01
US20050123604A1 (en) 2005-06-09
EP1492520A1 (en) 2005-01-05
AR038747A1 (es) 2005-01-26
PE20040288A1 (es) 2004-06-24
RU2318497C2 (ru) 2008-03-10
CN1638752A (zh) 2005-07-13
US20030171437A1 (en) 2003-09-11
JP2005519097A (ja) 2005-06-30
AU2003227039B9 (en) 2003-09-16
MXPA04008665A (es) 2004-12-06

Similar Documents

Publication Publication Date Title
PT1501534E (pt) Formulacoes farmaceuticas
DE60311307D1 (de) Shampoo-zusammensetzungen
FI20011478A0 (fi) Farmaseuttinen koostumus
PT1467724E (pt) Composicao farmaceutica orodispersavel de agomelatina
DK3384931T3 (da) Superfin formoterolformulering
NO20050132D0 (no) Vaksinesammensetning
NO20052306D0 (no) Dispergerbare farmasoytiske blandinger.
DE10393374D2 (de) Zusammensetzung
IS8309A (is) Lyfjablöndur
DK1587478T3 (da) Farmaceutisk sammensætning
DK1425019T3 (da) Farmaceutisk sammensætning omfattende et androgen
SE0500163L (sv) Sammansättning
EE200300589A (et) Ravimkoostised
DK1561472T3 (da) Faststofsammensætning
DE60320902D1 (de) Zusammensetzungen mit ausgelöster Freisetzung
DE60316954D1 (de) Shampoozusammensetzungen
FI20022128A0 (fi) Farmaseuttinen koostumus
PT1558263E (pt) Composicao farmaceutica de libertacao prolongada
BR0310113B1 (pt) Composições pesticidas
IS7581A (is) Lyfjasamsetning
NO20034952D0 (no) Farmasöytiske forbindelser
EE200300465A (et) Püridoindolooni derivaatidel põhinevad farmatseutilised kompositsioonid
ATE365529T1 (de) Schweisshemmende zusammensetzungen
NO20044164L (no) Farmasoytiske sammensetninger
NO20044140D0 (no) New Composition

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application